Related Posts
Who is hiring in the new year?
More Posts
Happy 2017, the year of the rooster
Should I take Siegfried Offer?
Who here is single and gay?
Additional Posts in Healthcare Consultants
New to Fishbowl?
Download the Fishbowl app to
unlock all discussions on Fishbowl.
unlock all discussions on Fishbowl.




They ghosted me after an initial interview. They seem to be a mini WITCH with lots of offshore influence. Losing their brand. Also, they seem weak in payer/provider.
Sorry you have given up. Good feedback for us and the team to tighten up ops. Wish you the best.
And yes we have a significant offshore presence. The India teams are very very capable of doing high end premium work. That is very different than staff aug. We reject staff aug RFPs regularly. But of course your source may have accurate examples as well that I’m not aware of.
Payor/Provider space is strong and growing over the last 3 years. Clients literally rave about the difference.
Zooming out, ZS is a great place to work. Not perfect, mind you, but truly values led.
Haha, this partner is really “selling” their brand 😂
HPP has tried to launch and failed several times - 2017, 2021. Sounds like they're up to it again. That said, if your experience is MA growth then you might be comfortable for a bit. Feel free to DM.
2017 and 2021 were not different “launches”. 2017 was the initial business case to proactively invest and 2021 was approval for another round of growth. 2024 was another tranche of growth approval. We grew from one client in 2018 to about 25 clients now in 2025.
Our solutions are not restricted to “sales”- in the early years, that was certainly the way to enter but a lot has changed in five years… in fact, most of our work today (80%) is not in the traditional sales/marketing work of which our pharma footprint has grown. We span many subdomains of transformation.
I would also say MA is not our primary LOB. Most of our project work is actually not in Medicare LOB. It’s mostly corporate strategy, commercial analytics, and VBC/MLR transformation. We do have a decent solution suite for MA spanning front, middle, and back office, and several GTM partnerships to help us commercialize them.
And yes we do a decent amount of work offshore. Not as high of a ratio as our peers in pharma but we are increasing it steadily and carefully to strike the right balance for our clients. Several of our clients (VP and above) have actually visited our India offices and signed contracts leveraging those capabilities shortly after their visit.
Sorry for the long-windedness here but maybe Manager 1 is working off a few older data points while we are on a growth journey that’s quite dynamic.
What P1 said, I concur.
Please DM me. I am intimately familiar with ZS’ payer/provider practice - our strategy, our challenges, and our opportunities. Any new space is hard, but can also be incredibly rewarding if it’s aligned to your goals and your strengths. Don’t mind those who give narrow blanket answers on this forum. You are presumably asking because you are curious about the possibility. And if you are serious, then have serious discussions. Not anonymous forum feedback.
If you want to dig in and grow something it’s a great firm in a young practice